期刊文献+

荧光分光光度法测定交联透明质酸凝胶中交联剂的残留量 被引量:4

Determination of free 1,4-butanediol diglycidyl ether in cross-linked hyaluronic acid gel by fluorospectrophotometry
原文传递
导出
摘要 目的:建立测定交联透明质酸凝胶中交联剂1,4-丁二醇二缩水甘油醚(BDDE)残留量的方法。方法:利用BDDE与烟酰胺产生的强荧光物质,在λex=370 nm/λem=430 nm检测其荧光强度,建立测定BDDE残留量的荧光分光光度法,并与气相色谱法进行比较。结果:在0.5~8.0μg.mL-1范围内,BDDE浓度和荧光强度有良好的线性关系,回归方程为y=76.729x-2.9517,r2=0.998;定量限为0.53μg.mL-1;平均回收率为99.4%,RSD=2.5%;市售样品中BDDE平均残留量为(1.47±0.41)μg.mL-1。气相色谱法定量限为1.85μg.mL-1,灵敏度和线性相关性均较差。结论:荧光分光光度法简单准确,灵敏度高,更适用于交联透明质酸凝胶的质量控制。 Objective:To establish a method of determining free 1,4-butanediol diglycidyl ether(BDDE) which is used as a cross-linking agent and a leftover remained in the cross-linked hyaluronic acid gel.Methods:Making use of strong fluorescent substance produced by BDDE and nicotinamide where excitation wavelength and emission wavelength were located at 370 nm and 430 nm respectively to detect its fluorescence intensity,to establish fluorospectrophotometry of testing BDDE residues and to make a comparison with gas chromatography.Results:The method had an excellent linear range of 0.5-8.0 μg·mL-1,y=76.729x-2.9517,r2=0.998.The quantification limit was 0.53 μg·mL-1.The average recovery of this method was 99.4%,RSD=2.5%.The content of BDDE in the cross-linked Hyaluronic acid gel produced in our lab was(1.47±0.41)μg·mL-1.The quantification limit of gas chromatography was 1.85 μg·mL-1,the sensitivity and linear correlation were worse than the fluorospectrophotometry.Conclusions:The fluorospectrophotometry was simple,accurate and highly sensitive.It was more suitable to the quality control of cross-linked hyaluronic acid gel.
出处 《药物分析杂志》 CAS CSCD 北大核心 2012年第4期654-657,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 医用植入材料 交联透明质酸凝胶 交联剂 1 4-丁二醇二缩水甘油醚(BDDE) 荧光分光光度法 气相色谱法 clinical embedded material cross-linked hyaluronic acid gel crosslinking agent 1 4-butanediol diglycidyl ether(BDDE) fluorospectrophotometry gas chromatography
  • 相关文献

参考文献5

二级参考文献41

  • 1贺艳丽,陈建英,王玉玲.交联透明质酸体外耐酶试验方法的研究[J].食品与药品,2005,7(01A):32-35. 被引量:4
  • 2贺艳丽,陈建英,刘杰,王玉玲,娄红祥.交联透明质酸膜的特性与生物相容性的初步研究[J].中国生化药物杂志,2006,27(1):25-28. 被引量:8
  • 3于学丽,王传栋,李保陆,曹成波.透明质酸的改性及其应用[J].生物医学工程研究,2005,24(1):61-66. 被引量:17
  • 4[1]Epstein J, Rosenthal R W, Ess R J. Anal. Chem.[J], 1955, 27(9): 1435.
  • 5[2]Miller R E, Guengerich F P. Biochemistry[J], 1982, 21: 1090.
  • 6[3]Rink R, Fennema M, Smids M et al. J. Biol. Chem.[J], 1997, 272(23): 14650.
  • 7[4]Zocher F, Enzelberger M M, Bornscheuer U T et al. Anal. Chim. Acta[J], 1999, 391: 345.
  • 8[5]Kolattukudy P E, Brown L. Arch Biochem. Biophys.[J], 1975, 166: 599.
  • 9[6]Pedragosa-Moreau S, Archelas A, Furstoss R. J. Org. Chem.[J], 1993, 58(20): 5533.
  • 10[7]Westkaemper R B, Hanzlik R P. Anal. Biochem.[J], 1980, 102: 63.

共引文献33

同被引文献63

  • 1林玉珍.透明质酸钠中蛋白质含量测定方法的比较[J].生物技术世界,2013,10(5):6-6. 被引量:3
  • 2王悦,李京,范慧红.交联玻璃酸钠注射液中残留交联剂乙烯砜的测定[J].中国生化药物杂志,2014,34(4):171-174. 被引量:5
  • 3赵华,何聪芬,兰社益,董银卯.天然防腐剂那他霉素的抑菌效果试验[J].北京工商大学学报(自然科学版),2005,23(4):13-15. 被引量:13
  • 4葛翠兰,顾其胜.交联透明质酸凝胶中交联剂的HPLC测定[J].上海生物医学工程,2006,27(4):223-225. 被引量:4
  • 5Maurice N. Collins,Colin Birkinshaw.Hyaluronic acid solutions—A processing method for efficient chemical modification[J].J Appl Polym Sci.2013(1)
  • 6Maurice N. Collins,Colin Birkinshaw.Hyaluronic acid based scaffolds for tissue engineering—A review[J].Carbohydrate Polymers.2013(2)
  • 7Jonathan M. Grasman,Raymond L. Page,Tanja Dominko,George D. Pins.Crosslinking strategies facilitate tunable structural properties of fibrin microthreads[J].Acta Biomaterialia.2012(11)
  • 8Maurice N. Collins,Colin Birkinshaw.Physical properties of crosslinked hyaluronic acid hydrogels[J].Journal of Materials Science: Materials in Medicine.2008(11)
  • 9Maurice N.Collins,ColinBirkinshaw.Investigation of the swelling behavior of crosslinked hyaluronic acid films and hydrogels produced using homogeneous reactions[J].J Appl Polym Sci.2008(2)
  • 10Laurent T C,Fraser J R,Hyalurona[J]. FASER J,1992,6(7) :2397 - 2404.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部